BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31940267)

  • 21. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation.
    Barlev AN; Malkiel S; Kurata-Sato I; Dorjée AL; Suurmond J; Diamond B
    J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 35819855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.
    Clatworthy MR; Matthews RJ; Doehler B; Willcocks LC; Opelz G; Smith KGC
    Transplantation; 2014 Aug; 98(3):285-291. PubMed ID: 25022320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein impairs immune response of CD8
    Jiang J; Peng Z; Wang J; Chen M; Wan Y; Huang H; Liu Z; Wang J; Hou J
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37844994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.
    Clynes RA; Towers TL; Presta LG; Ravetch JV
    Nat Med; 2000 Apr; 6(4):443-6. PubMed ID: 10742152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain natriuretic peptide induces CD8+ T cell death via a caspase 3 associated pathway--implications following heart transplantation.
    Shaw SM; Critchley WR; Puchalka CM; Williams SG; Yonan N; Fildes JE
    Transpl Immunol; 2012 Mar; 26(2-3):119-22. PubMed ID: 22138041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.
    Iwayanagi Y; Igawa T; Maeda A; Haraya K; Wada NA; Shibahara N; Ohmine K; Nambu T; Nakamura G; Mimoto F; Katada H; Ito S; Tachibana T; Jishage K; Hattori K
    J Immunol; 2015 Oct; 195(7):3198-205. PubMed ID: 26320252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.
    Rovira J; Renner P; Sabet-Baktach M; Eggenhofer E; Koehl GE; Lantow M; Lang SA; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A
    Am J Transplant; 2016 Apr; 16(4):1139-47. PubMed ID: 26855194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights in CD28-independent allograft rejection.
    Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
    Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B lymphocytes undergo apoptosis because of FcgammaRIIb stress response to infection: a novel mechanism of cell death in sepsis.
    Pinheiro-da-Silva F; Chiamolera M; Charles N; Kanamaru Y; Velasco IT; Benhamou M; Monteiro RC
    Shock; 2006 Jan; 25(1):61-5. PubMed ID: 16369188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.
    Nomura H; Wada N; Takahashi H; Kase Y; Yamagami J; Egami S; Iriki H; Mukai M; Kamata A; Ito H; Fujii H; Ishikura T; Koseki H; Watanabe T; Yamada T; Ohara O; Koyasu S; Amagai M
    J Immunol; 2022 Feb; 208(3):582-593. PubMed ID: 34996836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients.
    Erdinc Sunay MM; Fox-Talbot K; Velidedeoglu E; Baldwin WM; Wasowska BA
    Transplantation; 2013 Oct; 96(7):601-8. PubMed ID: 23903009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.